Per- and Polyfluoroalkyl Substances: An Emerging Contaminant of Concern

IMPACT: Innovative (nano)Materials and processes for advanced catalytic technologies to degrade PFOA in water

We hereby report the development of a novel electrochemical method to degrade perfluorooctanoic acid (C7F15COOH, PFOA). At the center of the approach are bimetallic Pd-Ru nano-catalyst materials called IMPACT: Innovative (nano)Materials and Processes for Advanced Catalytic Technologies. IMPACT uses flavonoid-sequestered Pd-Ru, allowing the development of specialized electrodes with tunable properties to sequentially degrade PFOA in wastewater samples into a sustainable byproduct via an indirect electrochemical method. Electron transfers at RuOxHy species stabilize the Pd component of the nano-catalysts, enabling the degradation process via PFOA deprotonation, chain shortening, decarboxylation, hydrolysis, fluoride elimination, and CF2 flake-off mechanism. IMPACT enabled the observation of redox peaks at -0.26 V and 0.56 V for the first time, with accompanying reduction peaks at -0.5V and 0.29 V, respectively. These redox peaks, which correlated with the concentrations of PFOA (20, 50, 100, 200, and 400. mg L-1), were verified and confirmed using electrochemical simulations. Control experiments did not show degradation of PFOA in the absence of Pd-Ru nano-catalyst. The degradation in wastewater was obtained within 3 h with an efficiency of 98.5%. The electrochemical degradation products of PFOA were identified using High-resolution desalting paper spray mass spectrometry (DPS-MS) and collision-induced dissociation (CID) analysis. The results yielded C2F5COOH, C3F7COOH, and C6F13OH with dissociation losses of CF2O or CO2. IMPACT introduces a novel nano-catalyst with high efficiency and a reliable capability that defluorinates strong C-F bonds that are components of recalcitrant organics in myriad environmental matrices.

Perfluorooctane sulfonic acid modulates expression of placental steroidogenesis-associated genes and hormone levels in pregnant rats

Perfluorooctane sulfonate (PFOS) is a widespread and persistent chemical in the environment. Reports show that PFOS is a potential endocrine disruptor; however, the possible effects of PFOS on placental endocrine function are unclear. This study aimed to investigate the endocrine-disrupting effects of PFOS on the placenta in pregnant rats and its potential mechanism. Pregnant rats from gestational days 4-20 were exposed to 0, 10, and 50 μg/mL PFOS through drinking water followed by analysis of various biochemical parameters. PFOS dose-dependently decreased fetal and placental weight in both sexes, with a specific decrease in weight of labyrinth but not junctional layer. Plasma progesterone (↑166%), aldosterone (↑201%), corticosterone (↑205%), testosterone (↑45%), luteinizing hormone (↑49%) levels were significantly increased, while estradiol (↓27%), prolactin (↓28%) and hCG (↓62%) levels were reduced in groups exposed to higher doses of PFOS. Real-time quantitative reverse transcriptase-polymerase chain reaction analysis revealed a significant increase in mRNA levels of placental steroid biosynthesis enzymes, including Cyp11A1 and 3β-HSD1 in male placenta and StAR, Cyp11A1, 17β-HSD1 and 17β-HSD3 in female placenta of PFOS dams. Cyp19A1 expression in ovaries was significantly decreased in PFOS dams. mRNA levels for placental steroid metabolism enzyme UGT1A1 increased in male but not in female placenta of PFOS dams. These results suggest that the placenta is a target tissue of PFOS and PFOS-induced dysregulation in steroid hormone production might be related to the altered expression of hormone biosynthesis and metabolism enzyme genes in the placenta. This hormone disruption might affect maternal health and fetal growth.

Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice

Polychlorinated biphenyl (PCB)126 and perfluorooctane sulfonic acid (PFOS) are halogenated organic pollutants of high concern. Exposure to these chemicals is ubiquitous, and can lead to potential synergistic adverse effects in individuals exposed to both classes of chemicals. The present study was designed to identify interactions between PCB126 and PFOS that might promote acute changes in inflammatory pathways associated with cardiovascular disease and liver injury. Male C57BL/6 mice were exposed to vehicle, PCB126, PFOS, or a mixture of both pollutants. Plasma and liver samples were collected at 48 h after exposure. Changes in the expression of hepatic genes involved in oxidative stress, inflammation, and atherosclerosis were investigated. Plasma and liver samples was analyzed using untargeted lipidomic method. Hepatic mRNA levels for Nqo1, Icam1, and PAI1 were significantly increased in the mixture-exposed mice. Plasma levels of PAI1, a marker of fibrosis and thrombosis, were also significantly elevated in the mixture-exposed group. Liver injury was observed only in the mixture-exposed mice. Lipidomic analysis revealed that co-exposure to the mixture enhanced hepatic lipid accumulation and elevated oxidized phospholipids levels. In summary, this study shows that acute co-exposure to PCB126 and PFOS in mice results in liver injury and increased cardiovascular disease risk.